Rectal pill may give days-long protection against HIV: Study
Could a quick-dissolving pill placed in the rectum prove to be an effective and safe "on-demand" way to prevent HIV infection among sexually active men and women?
Feb 22, 2023
0
3
Could a quick-dissolving pill placed in the rectum prove to be an effective and safe "on-demand" way to prevent HIV infection among sexually active men and women?
Feb 22, 2023
0
3
A man who underwent a stem cell transplant to treat his cancer is showing "strong evidence" that the procedure also cured him of HIV—the latest in a handful of cases doctors have reported.
Feb 20, 2023
0
100
A recent study performed in Zambia by University of Maryland School of Medicine's (UMSOM) Institute of Human Virology researchers found that high uptake of HIV preventative medicine, known as pre-exposure prophylaxis (PrEP), ...
Feb 15, 2023
0
30
Even though the COVID-19 public health emergency classification will expire this spring, the lingering effects of the pandemic remain. A constant puzzle to solve since the first year of the pandemic has been "long COVID," ...
Feb 14, 2023
0
138
For people at high risk of contracting HIV, missing doses of their daily HIV prevention pills can have big consequences. In some cases, missing a pill can lead to lack of protection against the virus.
Feb 9, 2023
0
26
A new survey finds that men who would be potential users of HIV pre-exposure prophylaxis (PrEP) medication prefer long-acting injections over pills, but rank side effects and costs as the most important issues for them in ...
Jan 31, 2023
0
10
Soon after infection, HIV-1 establishes a life-long presence by forming viral reservoirs in the body—cells that are infected with HIV but not actively producing new viruses. Antiretroviral therapy (ART) reduces HIV levels ...
Jan 10, 2023
0
32
The Adherence Connection for Counseling, Education, and Support (ACCESS) peer-led, mobile health cognitive behavioral antiretroviral therapy (ART) adherence intervention improves adherence to ART for adolescents and young ...
Jan 9, 2023
0
2
Silent but deadly. These are words often used to describe cervical cancer—a slow-growing disease that rarely causes symptoms in its early stages.
Jan 5, 2023
0
6
The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...
Dec 29, 2022
0
14